antibody therapy (Alchemab Therapeutics/Medicines discovery catapult)

N/A

Report date: 2025/03/14 16:34:05

Base Information

Drug Nameantibody therapy (Alchemab Therapeutics/Medicines discovery catapult)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsFrontotemporal DementiaAlzheimer DiseaseHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlchemab Therapeutics Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsFrontotemporal DementiaAlzheimer DiseaseHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A